100
Corbus Pharmaceuticals Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
60.2
FY23:
23.5
FY24:
153
FY25:
167
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.53
FY22:
6.13
FY23:
4.73
FY24:
2.90
FY25:
1.24
Total assets
Change from FY21 to FY25
millions USD
FY21:
108
FY22:
66.3
FY23:
28.3
FY24:
156
FY25:
168
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.0
FY22:
12.6
FY23:
31.9
FY24:
11.8
FY25:
20.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
21.6
FY22:
20.7
FY23:
3.28
FY24:
1.63
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
69.1
FY22:
33.0
FY23:
−6.91
FY24:
142
FY25:
148
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
108
FY22:
66.3
FY23:
28.3
FY24:
156
FY25:
168
All amounts in millions USD